These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29210149)

  • 1. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
    Lai CH; Yang YH; Chen PC; King YC; Liu CY
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
    Wu CM; Su FH; Muo CH; Huang JC; Wu MM; Yeh CC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
    Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
    World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
    Vujosevic S; Tempesta D; Noventa F; Midena E; Sebastiani G
    Hepatology; 2012 Aug; 56(2):455-63. PubMed ID: 22331668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
    Schulman JA; Liang C; Kooragayala LM; King J
    Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
    Kim ET; Kim LH; Lee JI; Chin HS
    Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
    Chang YK; Tseng YT; Chen KH; Chen KT
    BMC Endocr Disord; 2019 Apr; 19(1):36. PubMed ID: 30953492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.
    Saito H; Ebinuma H; Nagata H; Inagaki Y; Saito Y; Wakabayashi K; Takagi T; Nakamura M; Katsura H; Oguchi Y; Ishii H
    Liver; 2001 Jun; 21(3):192-7. PubMed ID: 11422782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Adams S; Ostermeier M
    Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-related retinopathy in a man with chronic hepatitis C].
    Viennet A; Glatre F; Bacin F
    J Fr Ophtalmol; 2009 Sep; 32(7):505-10. PubMed ID: 19592135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report].
    Avila MP; Freitas AM; Isaac DL; Bastos AL; Pena RV
    Arq Bras Oftalmol; 2006; 69(2):255-9. PubMed ID: 16699680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.
    Panetta JD; Gilani N
    Aliment Pharmacol Ther; 2009 Sep; 30(6):597-602. PubMed ID: 19549263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
    Hara K; Tanito M; Ohira A
    Acta Ophthalmol; 2012 Mar; 90(2):e158-60. PubMed ID: 21649866
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
    Tsolakos A; Zalatimo N
    Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
    Novelli FJ; Przysiezny A; Rosa EL; Garcia RF; Nóbrega MJ
    Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.